<DOC>
	<DOCNO>NCT01374113</DOCNO>
	<brief_summary>The primary purpose trial investigate pharmacokinetics ( behaviour compound body ) safinamide subject different degree renal impairment comparison match subject normal renal function .</brief_summary>
	<brief_title>Safinamide Renal Impairment Trial</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>1 . Renally impaired subject Subject different degree renal impairment : moderate severe renal impairment assess Estimated Glomerular Filtration Rate ( eGFR ) accord Modification Diet Renal Disease ( MDRD ) equation screen 2 . Healthy subject Subject good ageappropriate physical mental health establish medical history , physical examination , electrocardiogram ( ECG ) vital sign recording , result biochemistry , haematology , coagulation urinalysis test within 3 week prior dose 3 . All subject give write informed consent studyrelated activity carry 1 . Any clinically relevant disease , condition , therapy , Investigator 's opinion would exclude subject trial , may pose risk subject interfere trial objective . 2 . Existence surgical medical condition , , judgment Investigator , might interfere absorption , metabolism , excretion drug and/or gastrointestinal motility 3 . Renally impaired subject Acute renal failure etiology ( include viral , toxic , drug induce ) , renal transplantation within previous 12 month , uncontrolled diabetes mellitus judge Investigator , use drug affect gastric acid secretion , proton pump inhibitor antacids receive within 48 hour prior drug administration 24 hour administration , Chronic heart failure ( CHF ) New York Heart Association ( NYHA ) class III IV despite treatment screening , change use medication ( prescribed physician overthecounter [ OTC ] medication ) within 14 day prior safinamide administration . Concomitant medication use treatment renal impairment accompany disease may continue trial . 4 . Healthy subject Use medication , include multivitamin preparation , receive within 21 day prior drug administration ( within six time elimination halflife , whichever long ) , except combine oral contraceptive occasional use paracetamol ibuprofen within 14 day trial drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>safinamide</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>renal impairment</keyword>
	<keyword>Moderate Severe Renal Impairment</keyword>
</DOC>